Publikationen, an denen er mitarbeitet ALEJANDRO LOPEZ SOTO (48)

2023

  1. BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia

    Cancer Immunology, Immunotherapy, Vol. 72, Núm. 7, pp. 2529-2539

2022

  1. Autophagy-linked plasma and lysosomal membrane protein PLAC8 is a key host factor for SARS-CoV-2 entry into human cells

    EMBO Journal, Vol. 41, Núm. 21

2021

  1. Btla/hvem axis induces nk cell immunosuppression and poor outcome in chronic lymphocytic leukemia

    Cancers, Vol. 13, Núm. 8

  2. Lag‐3 blockade with relatlimab (Bms‐986016) restores anti‐leukemic responses in chronic lymphocytic leukemia

    Cancers, Vol. 13, Núm. 9

2020

  1. A cytofluorimetric assay to evaluate intracellular cytokine production by NK cells

    Methods in Enzymology (Academic Press Inc.), pp. 343-355

  2. Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT

    Bone Marrow Transplantation

  3. Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay

    Methods in Enzymology (Academic Press Inc.), pp. 483-495

  4. Mechanisms of apoptosis resistance to NK cell-mediated cytotoxicity in cancer

    International Journal of Molecular Sciences, Vol. 21, Núm. 10

  5. Mechanisms of resistance to NK cell immunotherapy

    Cancers, Vol. 12, Núm. 4

2019

  1. A flow cytometric NK cell-mediated cytotoxicity assay to evaluate anticancer immune responses In vitro

    Methods in Molecular Biology (Humana Press Inc.), pp. 131-139

  2. CD107a degranulation assay to evaluate immune cell antitumor activity

    Methods in Molecular Biology (Humana Press Inc.), pp. 119-130

  3. Immunosurveillance of cancer cell stress

    Cell Stress, Vol. 3, Núm. 9, pp. 295-309

  4. NK cell-based immunotherapy in cancer metastasis

    Cancers, Vol. 11, Núm. 1

  5. The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling

    Frontiers in Immunology, Vol. 10

2018

  1. Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia

    Frontiers in immunology, Vol. 9, pp. 2917

  2. NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines

    Cancer Research, Vol. 78, Núm. 14, pp. 3913-3925

2017

  1. Biallelic IRF8 Mutations Causing NK Cell Deficiency

    Trends in Molecular Medicine

  2. Control of Metastasis by NK Cells

    Cancer Cell, Vol. 32, Núm. 2, pp. 135-154

  3. IFN Signaling and ICB Resistance: Time is on Tumor's Side

    Trends in Cancer

  4. Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia

    OncoImmunology, Vol. 6, Núm. 10